Rupee declines 16 paise to 75.17 against US dollar in early trade

The rupee opened weak at 75.13 at the interbank forex market, then lost further ground and touched 75.17 against the US dollar, down 16 paise over its previous close of 75.01.
Hindustan Times, 5 min(s) ago
Also from: Hindu Business Line, Hindustan Times

JSPL reports 25% rise in July steel sales, production up by 13% to 6,03,000 tonnes

The company’s standalone steel sales rose by 29% in July 2020 to 6,37,000 tonnes as compared to standalone sales of 4,93,000 tonnes in the previous year during the same period. “India Inc is getting back to normalcy, as companies can mend supply chains, ...
Economic Times, 23 min(s) ago
Also from: Rediff.com, Money Control and 1 other source

TikTok saga continues with Microsoft talks. Now what?

The latest twist in the TikTok saga is an especially strange turn in a tale filled with strange turns. Suddenly, Microsoft -- known primarily for work software like Windows and Office -- is in talks to buy the popular Chinese-owned video app, which has raised ...
Times of India, 2 hour(s) ago
Also from: Money Control, Hindu Business Line and 3 other sources

Wockhardt shares surge 24% in 3 days on deal for COVID-19 vaccine with UK govt

The agreement is for 30 million doses, which can be expanded to 400 million doses in the UK.
Money Control, 1 hour(s) ago
Also from: Hindu Business Line, Money Control and 1 other source

Sensex spurts 250 points in early trade on fund inflows

Entrepreneurs, by their DNA, are problem solvers: Vaitheeswaran
Hindu Business Line, 1 hour(s) ago
Also from: Hindu Business Line, Rediff.com and 1 other source

How Biocon plans to fight COVID-19

'I cannot cope with the demand. It will take us a couple of months to ramp up production.' Bio-pharmaceutical company Biocon, which saw a decline in its profit in Q1FY21 despite a double digit growth in topline, is betting big on two recent developments. The first one is the company's voluntary licencing agreement with Gilead to manufacture Remdesivir, the anti-viral drug which is said to be suitable for treating mild to moderate COVID-19 patients. The second one is the company's novel ...
Rediff.com, 1 hour(s) ago
Also from: Economic Times

SpiceJet withdraws promotional offer after DGCA flags violation of ticket fare terms: Report

Spicejet had announced a five-day 1 1 special offer on August 3 as a means to boost ticket sales amid the coronavirus pandemic
Money Control, 2 hour(s) ago
Also from: Money Control, Times of India and 1 other source

Trade Spotlight: Bandhan Bank, Tata Motors UPL in focus

Stocks like Bandhan Bank which was down by over 10 percent, Tata Motors (up 8%), and UPL which was also the top Nifty loser post June quarter results in the previous session were in focus.
Money Control, 2 hour(s) ago
Also from: Money Control, NDTV and 4 other sources

Covid: Jubilant Generics launches remdesivir injection at ₹4,700 per vial

JUBI-R will be made available in over 1,000 hospitals providing Covid-19 treatment
Hindu Business Line, 1 hour(s) ago
Also from: Rediff.com, Economic Times

Is the upward trend seen in the markets sustainable?

Reasons behind the present market rally are not good enough to support the market in the long run, says Dhirendra Kumar
Value Research Online, 12 hour(s) ago
Also from: Rediff.com, Money Control